Dutch Bros stock gets buy rating resume from Stifel on growth outlook

Stifel resumed coverage of Dutch Bros with a Buy rating and a $48 price target, implying 42% upside from $33.77, based on a 19.5x EV/EBITDA multiple applied to fiscal 2027 estimates. Stifel forecasts 187 store openings in fiscal 2026 and 250 in fiscal 2027, while projecting comparable sales growth of 5.2% for fiscal 2026 and 3.5% for fiscal 2027 after quarterly comps slowed to 4.4% in Q3 2026. Recent results were mixed: adjusted EBITDA rose 30% to $101 million and beat consensus, but comparable sales of 4.4% fell short of the 4.6% estimate; several other firms cut their price targets.

Analysis

The central debate is not whether Dutch Bros can open stores, but whether incremental units earn attractive returns as the footprint densifies. A growing opening cadence can support revenue while masking weaker mature-store demand, cannibalization, or longer payback periods; the article provides no cohort-level returns or cash-on-cash data to validate that risk. The deceleration in comps therefore matters disproportionately: it can pressure both near-term operating leverage and the valuation multiple applied to out-year EBITDA. Stifel’s target depends on FY2027 execution and a higher multiple than the trailing metric cited, so the stated upside is a scenario, not an independently established valuation floor.

Over the next 1–3 months, the key catalyst is management’s evidence that new-store productivity and margins hold up alongside expansion—not simply the opening count. Over 6–18 months, sustained unit returns could support a growth premium; evidence of cannibalization or weaker payback could instead make expansion value-destructive. Broader coffee competition, including Starbucks and regional drive-through operators, is a potential pressure on traffic and labor economics, but the article provides no evidence of a specific share shift. The contrarian opportunity is that negative revisions may already have lowered expectations; however, the data here do not establish that the stock is mispriced.

Key Decisions for Investors

• Do not underwrite the $48 target as a near-term valuation anchor. Keep BROS on a watchlist until the next results clarify same-store sales, store-level margins, new-unit payback, and whether guidance still supports the planned opening pace.
• For a growth-oriented book, consider only a staged long after evidence that new-store returns remain sound while comps stabilize; use a close below the cited $33.17 52-week low as a review/invalidation trigger, not as a guaranteed support level. The trade’s upside requires execution and multiple support, so size accordingly.
• Reassess over the next 1–3 months on comp trends and guidance, and over 6–18 months on cohort returns and cannibalization. Falsify the long thesis if comps weaken further, management reduces the opening plan, or store-level economics deteriorate; no clean pair trade is supported by the supplied evidence.